Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
MINNEAPOLIS, May 24, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today provided its initial revenue outlook and diluted earnings per share (EPS) guidance for fiscal year 2012. The company...
PARIS, May 20, 2011 (BUSINESS WIRE) -- A pooled analysis of the global RESOLUTE clinical program presented today during a late-breaking clinical trials session at EuroPCR demonstrated the strong...
PARIS, May 20, 2011 (BUSINESS WIRE) -- A late-breaking presentation about transcatheter aortic valve implantation (TAVI) at EuroPCR 2011 today confirmed positive outcomes in patients receiving the...
PARIS, May 19, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today issued a statement on results of clinical data presented at EuroPCR 2011 that show the Medtronic CoreValve(R) System,...
PARIS, May 18, 2011 (BUSINESS WIRE) -- For patients with both heart disease and diabetes who took part in a pooled series of rigorous clinical trials, the Resolute drug-eluting stent (DES) from...